The growing worldwide incidence of melanoma and nonmelanoma skin cancers has driven the development of effective treatment methodologies. Mohs is the gold standard surgical treatment for excision of skin cancers on the head and neck. While Mohs surgery has a 99% effectiveness rate for new cancers and 95% for recurrences, more than 90% of reconstructed patients desire some improvement in their operative scars.